Manufactured Object – Page 15

GLP-1 Weight Loss Drugs Make Super Bowl Advertising Debut Amid Shifting Health Marketing Landscape

7 months ago talkbio0Tagged Epidemic, Glucagon-Like Peptide 1, Health care facility, Hims & Hers, Obesity, pharmaceutical marketing, Super Bowl ads, Weight-Loss Agents

GLP-1, Super Bowl ads, Hims & Hers, weight loss drugs, pharmaceutical marketing, healthcare advertising, obesity epidemic

AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction

7 months ago talkbio0Tagged Administration occupational activities, AstraZeneca, Drug Industry, Economic Growth, Government, Investments, Labor (Childbirth), Manufacturing, UK, Vaccines

AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

7 months ago talkbio0Tagged Administration occupational activities, ambulatory care services, Aortic Valve Insufficiency, deal activity, digital health, expansion, Gene Modification, Health care facility, Pharmaceutical Services, regulatory environment, Transplant Registry Unified Management Program

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration

New year starts with a bang as trio of venture financings brings in $382M

7 months ago talkbio0Tagged biotech, Capital, Investments, Life, Megarounds, Private financing, Tenvie, venture

Venture capital, Biotech funding, Megarounds, Tenvie Therapeutics, Private financing, Life sciences investments

Secretary Rubio Expands Humanitarian Exemptions in US Foreign Aid Freeze

8 months ago talkbio0Tagged Freezing, global health programs, Humanitarian Exemptions, International Aspects, Manufactured Supplies, Marco Rubio, United States Agency for International Development

Marco Rubio, foreign aid freeze, humanitarian exemptions, USAID, medicine supplies, global health programs

Aurion Biotech Presses On with IPO Plans Amid Legal Dispute with Investor Alcon

8 months ago talkbio0Tagged Alcon, biotech, Bovichtus, Cell Therapy, Investments, IPO, Legal

Aurion Biotech, IPO, legal dispute, Alcon, cell therapy, biotech investment

AstraZeneca Invests $570M in Canadian Expansion, Creating 700 New Jobs

8 months ago talkbio0Tagged AstraZeneca, Canadian, Clinical Trials, Drug Industry, expansion, Investments, R&D

AstraZeneca, Canadian expansion, $570M investment, 700 new jobs, life sciences, R&D, clinical trials, pharmaceutical industry

Retro Biosciences, Backed by Sam Altman, Seeks $1 Billion to Extend Human Lifespan by 10 Years

8 months ago talkbio0Tagged Altman, Artificial (qualifier value), Biosciences, Biotechnology, Dorsal, Funding, Health care facility, Homo sapiens, Intelligence, Lifespan Extension, Series

Retro Biosciences, Sam Altman, Human Lifespan Extension, Biotechnology, Series A Funding, Artificial Intelligence in Healthcare

Sionna and Odyssey Therapeutics Kick Off 2025 Biotech IPO Wave with SEC Filings

8 months ago talkbio0Tagged 2025, File (record), Health care facility, Industry, IPO, JPM, Market, Odyssey, Sionna

Sionna Therapeutics, Odyssey Therapeutics, IPO filings, biotech industry, JPM Healthcare Conference, 2025 IPO market

InnoCare and KeyMed Secure $520M Licensing Deal for Bispecific Antibody with RTW-Built Biotech

8 months ago talkbio0Tagged Antibodies, Bispecific, InnoCare, Investments, KeyMed, Licensing, RTW

InnoCare, KeyMed, Bispecific Antibody, RTW Investments, Licensing Deal, $520M